| HGNC Family | G protein-coupled receptors |
| Name | prostaglandin I2 (prostacyclin) receptor (IP) |
| Description | The protein encoded by this gene is a member of the G-protein coupled receptor family 1 and has been shown to be a receptor for prostacyclin. Prostacyclin, the major product of cyclooxygenase in macrovascular endothelium, elicits a potent vasodilation and inhibition of platelet aggregation through binding to this receptor. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPTGIR, the gene encoding the prostacyclin (PGI₂) receptor, is essential for cardiovascular homeostasis. The receptor mediates potent vasodilatory and antithrombotic actions by coupling predominantly to Gs proteins to stimulate cyclic AMP production, thereby inhibiting platelet aggregation, modulating endothelial ATP release, and counterbalancing the pro‐aggregatory effects of thromboxane. Functionally detrimental receptor variants (for example, those affecting residues such as R212) have been linked to enhanced platelet aggregation and accelerated atherothrombosis, while altered receptor signaling has been observed in conditions including aspirin‐intolerant asthma and deep vein thrombosis. These studies collectively underscore PTGIR’s vital contribution to maintaining vascular tone and hemostatic balance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, proper PTGIR function requires a precisely organized receptor structure. Structure–function investigations have revealed that conserved residues within the transmembrane domains, extracellular loops, and intracellular regions create a unique ligand-binding pocket and are critical for efficient G protein coupling. Post-translational modifications—including isoprenylation and farnesylation of the cytoplasmic tail—as well as the presence of specific cysteines and charged residues, ensure accurate receptor folding, trafficking, and internalization (via interactions with proteins such as Rab11a). High-throughput mutagenesis studies have further delineated key motifs and intracellular loop domains (e.g. the first intracellular loop) that underlie efficient signal transduction by enabling effective coupling to downstream effectors."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its core role in vascular regulation, PTGIR expression and signaling are intricately modulated by a range of regulatory mechanisms that extend its functional repertoire to diverse biological systems. Hormonal regulators—such as estrogens and androgens—as well as transcriptional and epigenetic factors, modulate PTGIR gene expression and receptor density in endothelial cells, megakaryocytes, and other tissues. PTGIR also forms hetero-oligomeric complexes with other receptors (for example, with thromboxane, ghrelin, and epidermal growth factor receptors) to fine-tune cellular responses in angiogenesis, immune cell differentiation, adipocyte “browning,” and even neuronal precursor activity. Genetic polymorphisms in the PTGIR gene have been associated with variations in receptor function and platelet responsiveness, predisposing individuals to disorders such as fibromuscular dysplasia, spontaneous coronary artery dissection, and altered inflammatory responses. Furthermore, PTGIR-mediated signaling influences nonvascular functions including hair growth regulation and the processing of amyloid precursor protein in brain microvessels, underscoring its multifaceted role in human physiology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "44"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Eric Arehart, Jeremiah Stitham, Folkert W Asselbergs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.107.165936"}], "href": "https://doi.org/10.1161/CIRCRESAHA.107.165936"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18323528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18323528"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Stephen J Wilson, Aoife M Roche, Ekaterina Kostetskaia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M405002200"}], "href": "https://doi.org/10.1074/jbc.M405002200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15471868"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15471868"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kristina M Fetalvero, Maureen Shyu, Athena P Nomikos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00936.2005"}], "href": "https://doi.org/10.1152/ajpheart.00936.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16399867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16399867"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Sang-Heon Kim, Yoon-Keun Kim, Heung-Woo Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.fpc.0000239977.61841.fe"}], "href": "https://doi.org/10.1097/01.fpc.0000239977.61841.fe"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17496729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17496729"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Emer M Smyth, Garret A FitzGerald "}, {"type": "b", "children": [{"type": "t", "text": "Human prostacyclin receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Vitam Horm (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0083-6729(02)65063-0"}], "href": "https://doi.org/10.1016/s0083-6729(02"}, {"type": "t", "text": "65063-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12481546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12481546"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Meera Sridharan, Elizabeth A Bowles, Jennifer P Richards, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00998.2011"}], "href": "https://doi.org/10.1152/ajpheart.00998.2011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22159995"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22159995"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jeremiah Stitham, Aleksandar Stojanovic, John Hwa "}, {"type": "b", "children": [{"type": "t", "text": "Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M201187200"}], "href": "https://doi.org/10.1074/jbc.M201187200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11854299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11854299"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Paola Patrignani, Concetta Di Febbo, Stefania Tacconelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e328301a774"}], "href": "https://doi.org/10.1097/FPC.0b013e328301a774"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18551041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18551041"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Takahiro Osawa, Noritaka Ohga, Yasuhiro Hida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2012.02261.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2012.02261.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22380928"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22380928"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Salam Ibrahim, Mazell Tetruashvily, Alex J Frey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.110.208900"}], "href": "https://doi.org/10.1161/ATVBAHA.110.208900"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20522800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20522800"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jeremiah Stitham, Eric Arehart, Larkin Elderon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.124933"}], "href": "https://doi.org/10.1074/jbc.M110.124933"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21189259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21189259"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Mie Shimizu, Shinichi Yoshimura, Shunya Takizawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of single nucleotide polymorphisms of the prostacyclin receptor gene on platelet activation in Japanese healthy subjects and patients with cerebral infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Neurosci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jocn.2012.06.011"}], "href": "https://doi.org/10.1016/j.jocn.2012.06.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23628440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23628440"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jeremiah Stitham, Aleksandar Stojanovic, Bethany L Merenick, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M207420200"}], "href": "https://doi.org/10.1074/jbc.M207420200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12446735"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12446735"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Katarina Wikström, Helen M Reid, Maria Hill, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recycling of the human prostacyclin receptor is regulated through a direct interaction with Rab11a GTPase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2008.09.003"}], "href": "https://doi.org/10.1016/j.cellsig.2008.09.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18832025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18832025"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Sinead M Miggin, Orlaith A Lawler, B Therese Kinsella "}, {"type": "b", "children": [{"type": "t", "text": "Investigation of a functional requirement for isoprenylation by the human prostacyclin receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Biochem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1432-1327.2002.02817.x"}], "href": "https://doi.org/10.1046/j.1432-1327.2002.02817.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11895442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11895442"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jeremiah Stitham, Scott R Gleim, Karen Douville, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Versatility and differential roles of cysteine residues in human prostacyclin receptor structure and function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M604042200"}], "href": "https://doi.org/10.1074/jbc.M604042200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17015447"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17015447"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Jeremiah Stitham, Aleksandar Stojanovic, Lauren A Ross, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clusters of transmembrane residues are critical for human prostacyclin receptor activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi0496788"}], "href": "https://doi.org/10.1021/bi0496788"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15248755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15248755"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sarah J O'Meara, B Therese Kinsella "}, {"type": "b", "children": [{"type": "t", "text": "The effect of the farnesyl protein transferase inhibitor SCH66336 on isoprenylation and signalling by the prostacyclin receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20041290"}], "href": "https://doi.org/10.1042/BJ20041290"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15469414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15469414"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "J Stitham, E Arehart, S R Gleim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjp.0707413"}], "href": "https://doi.org/10.1038/sj.bjp.0707413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17704830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17704830"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lihai Zhang, Gangxiong Huang, Jiaxin Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A profile of the residues in the first intracellular loop critical for Gs-mediated signaling of human prostacyclin receptor characterized by an integrative approach of NMR-experiment and mutagenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi050483p"}], "href": "https://doi.org/10.1021/bi050483p"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16114876"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16114876"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Anke Bill, Elizabeth M Rosethorne, Toby C Kent, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High throughput mutagenesis for identification of residues regulating human prostacyclin (hIP) receptor expression and function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0097973"}], "href": "https://doi.org/10.1371/journal.pone.0097973"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24886841"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24886841"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Rico K H Lo, Andrew M F Liu, Helen Wise, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2008.08.003"}], "href": "https://doi.org/10.1016/j.cellsig.2008.08.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18755267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18755267"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Laurent Colombe, Jean-François Michelet, Bruno Alain Bernard "}, {"type": "b", "children": [{"type": "t", "text": "Prostanoid receptors in anagen human hair follicles."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Dermatol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1600-0625.2007.00639.x"}], "href": "https://doi.org/10.1111/j.1600-0625.2007.00639.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18005048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18005048"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Antonio Grilo, María P Sáez-Rosas, Juan Santos-Morano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e328341041c"}], "href": "https://doi.org/10.1097/FPC.0b013e328341041c"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21052031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21052031"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "David F Lewis, Bernard J Canzoneri, Yang Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Reprod Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1600-0897.2010.00861.x"}], "href": "https://doi.org/10.1111/j.1600-0897.2010.00861.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20482519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20482519"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Rayane A Ghandour, Maude Giroud, Alexandros Vegiopoulos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IP-receptor and PPARs trigger the conversion of human white to brite adipocyte induced by carbaprostacyclin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbalip.2016.01.007"}], "href": "https://doi.org/10.1016/j.bbalip.2016.01.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26775637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26775637"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Wenxuan Liu, Hui Li, Xiaojing Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostaglandins Leukot Essent Fatty Acids (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.plefa.2013.08.006"}], "href": "https://doi.org/10.1016/j.plefa.2013.08.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24035274"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24035274"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Oliver P Milling Smith, Sharon Battersby, Kurt J Sales, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostacyclin receptor up-regulates the expression of angiogenic genes in human endometrium via cross talk with epidermal growth factor Receptor and the extracellular signaling receptor kinase 1/2 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2005-1073"}], "href": "https://doi.org/10.1210/en.2005-1073"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16373414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16373414"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Elizebeth C Turner, Eamon P Mulvaney, Helen M Reid, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E11-04-0374"}], "href": "https://doi.org/10.1091/mbc.E11-04-0374"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21653824"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21653824"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Robert Pape, Bernhard H Rauch, Anke C Rosenkranz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.107.159483"}], "href": "https://doi.org/10.1161/ATVBAHA.107.159483"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18162607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18162607"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Adrien Georges, Juliette Albuisson, Takiy Berrandou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvaa161"}], "href": "https://doi.org/10.1093/cvr/cvaa161"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32531060"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32531060"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Elizebeth C Turner, B Therese Kinsella "}, {"type": "b", "children": [{"type": "t", "text": "Estrogen increases expression of the human prostacyclin receptor within the vasculature through an ERalpha-dependent mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2010.01.010"}], "href": "https://doi.org/10.1016/j.jmb.2010.01.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20070947"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20070947"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Richard A Bundey, Paul A Insel "}, {"type": "b", "children": [{"type": "t", "text": "Adenylyl cyclase 6 overexpression decreases the permeability of endothelial monolayers via preferential enhancement of prostacyclin receptor function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.106.028035"}], "href": "https://doi.org/10.1124/mol.106.028035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16885208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16885208"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Rico K H Lo, Helen Wise, Yung H Wong "}, {"type": "b", "children": [{"type": "t", "text": "Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2005.05.001"}], "href": "https://doi.org/10.1016/j.cellsig.2005.05.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15979846"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15979846"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Sri N Batchu, Syamantak Majumder, Bridgit B Bowskill, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin I2 Receptor Agonism Preserves β-Cell Function and Attenuates Albuminuria Through Nephrin-Dependent Mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db15-0783"}], "href": "https://doi.org/10.2337/db15-0783"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26868296"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26868296"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jeremiah Stitham, Eric J Arehart, Scott Gleim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2007.03.016"}], "href": "https://doi.org/10.1016/j.gene.2007.03.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17481829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17481829"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Zuzana Moravcová, Vladimír Rudajev, Jirí Stöhr, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2003.12.004"}], "href": "https://doi.org/10.1016/j.bbamcr.2003.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15053924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15053924"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Kevin B S Chow, Po-Ki Leung, Christopher H K Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The constitutive activity of ghrelin receptors is decreased by co-expression with vasoactive prostanoid receptors when over-expressed in human embryonic kidney 293 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2008.05.008"}], "href": "https://doi.org/10.1016/j.biocel.2008.05.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18573679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18573679"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Tongrong He, Anantha Vijay R Santhanam, Tong Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-α in cerebral microvessels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cereb Blood Flow Metab (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0271678X15618977"}], "href": "https://doi.org/10.1177/0271678X15618977"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26661245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26661245"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Elizebeth C Turner, B Therese Kinsella "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2008.12.030"}], "href": "https://doi.org/10.1016/j.jmb.2008.12.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19118563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19118563"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Sarah B Eivers, B Therese Kinsella "}, {"type": "b", "children": [{"type": "t", "text": "Regulated expression of the prostacyclin receptor (IP) gene by androgens within the vasculature: Combined role for androgens and serum cholesterol."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2016.06.011"}], "href": "https://doi.org/10.1016/j.bbagrm.2016.06.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27365208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27365208"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Feng Ni, Shui-Ping So, Vanessa Cervantes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A profile of the residues in the second extracellular loop that are critical for ligand recognition of human prostacyclin receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2007.06183.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2007.06183.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18042246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18042246"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Helen M Reid, Elizebeth C Turner, Eamon P Mulvaney, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction of the human prostacyclin receptor and the NHERF4 family member intestinal and kidney enriched PDZ protein (IKEPP)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2012.07.015"}], "href": "https://doi.org/10.1016/j.bbamcr.2012.07.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22884631"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22884631"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Garret L Keating, Elizebeth C Turner, B Therese Kinsella "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of the human prostacyclin receptor gene in megakaryocytes: major roles for C/EBPδ and PU.1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2012.02.010"}], "href": "https://doi.org/10.1016/j.bbagrm.2012.02.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22381139"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22381139"}]}]}]}
|
| Synonyms | IP, PRIPR |
| Proteins | PI2R_HUMAN |
| NCBI Gene ID | 5739 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PTGIR has 5,510 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 117 datasets.
Click the + buttons to view associations for PTGIR from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PTGIR gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PTGIR gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PTGIR gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PTGIR gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PTGIR gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PTGIR gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving PTGIR protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGIR gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PTGIR gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PTGIR gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PTGIR gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PTGIR gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGIR gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PTGIR gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PTGIR gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PTGIR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PTGIR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PTGIR gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PTGIR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PTGIR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PTGIR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PTGIR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PTGIR gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PTGIR gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PTGIR gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PTGIR gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PTGIR gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with PTGIR gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PTGIR gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PTGIR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PTGIR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PTGIR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PTGIR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PTGIR protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PTGIR gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PTGIR gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PTGIR gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PTGIR from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PTGIR gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PTGIR gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGIR gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PTGIR gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PTGIR from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PTGIR gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PTGIR gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PTGIR gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PTGIR gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PTGIR gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PTGIR gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PTGIR gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PTGIR gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PTGIR gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PTGIR protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PTGIR gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PTGIR gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PTGIR gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PTGIR gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PTGIR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PTGIR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PTGIR gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PTGIR gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding PTGIR receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with PTGIR gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PTGIR gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PTGIR gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PTGIR gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGIR gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PTGIR protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGIR gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PTGIR gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PTGIR gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PTGIR from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PTGIR gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PTGIR protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PTGIR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PTGIR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PTGIR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate PTGIR protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving PTGIR protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving PTGIR protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PTGIR gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PTGIR gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PTGIR gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PTGIR gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PTGIR protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PTGIR gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PTGIR gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PTGIR gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PTGIR gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PTGIR gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PTGIR gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PTGIR from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PTGIR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PTGIR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PTGIR protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PTGIR protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with PTGIR protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate PTGIR protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving PTGIR protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving PTGIR protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PTGIR protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PTGIR gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PTGIR gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PTGIR gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PTGIR gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PTGIR gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PTGIR gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PTGIR gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PTGIR gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PTGIR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PTGIR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PTGIR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PTGIR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PTGIR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PTGIR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PTGIR protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PTGIR protein from the WikiPathways Pathways 2024 dataset. | |